scholarly journals P6368Prevalence and prognostic significance of negative U-waves in the 12-lead electrocardiogram in the general population

2017 ◽  
Vol 38 (suppl_1) ◽  
Author(s):  
A.K. Holkeri ◽  
A. Eranti ◽  
M.A. Haukilahti ◽  
T.V. Kentta ◽  
T. Kerola ◽  
...  
2020 ◽  
Vol 58 ◽  
pp. 176-183
Author(s):  
Tiia Istolahti ◽  
Tuomo Nieminen ◽  
Heini Huhtala ◽  
Leo-Pekka Lyytikäinen ◽  
Mika Kähönen ◽  
...  

2013 ◽  
Vol 35 (2) ◽  
pp. 123-129 ◽  
Author(s):  
A. L. Aro ◽  
O. Anttonen ◽  
T. Kerola ◽  
M. J. Junttila ◽  
J. T. Tikkanen ◽  
...  

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Yasuharu Tabara ◽  
Kazuya Setoh ◽  
Takahisa Kawaguchi ◽  
Shinji Kosugi ◽  
Takeo Nakayama ◽  
...  

AbstractCirculating levels of inflammatory proteins have to be prognostic markers of all-cause mortality. α1-Antitrypsin (AAT) is a major inflammatory plasma protein, but its association with all-cause mortality is unclear. We aimed to evaluate the prognostic significance of AAT levels for all-cause mortality. Study participants comprised 9682 community residents (53.5 ± 13.3 years old). During the 9.8-year follow-up period, 313 participants died from any cause. The mortality rate increased linearly with AAT quintiles (Q1, 18.2; Q2, 24.7; Q3, 23.8; Q4, 31.9; Q5, 64.6 per 10,000 person-years). There were significant correlations between AAT and high-sensitivity C-reactive protein (hsCRP) levels (correlation coefficient, 0.331; P < 0.001). However, the Cox model analysis, when adjusted for possible covariates including hsCRP, identified the fifth AAT quintile as a risk factor for all-cause death (hazard ratio, 2.12 [95% confidence interval, 1.41–3.18]; P < 0.001). An analysis of participants older than 50 years (hazard ratio, 1.98, P < 0.001) yielded similar results. The hazard ratio increased proportionately in combination with high AAT and high hsCRP levels, and the highest hazard ratio reached 4.51 (95% confidence interval, 3.14–6.54, P < 0.001). High AAT levels were determined to be an independent risk factor for mortality in the general population.


2013 ◽  
Vol 31 (15_suppl) ◽  
pp. 2028-2028
Author(s):  
Anna Luisa Di Stefano ◽  
Giuseppe Lombardi ◽  
Jaime Gallego Perez-Larraya ◽  
Blandine Boisselier ◽  
Marianne Labussiere ◽  
...  

2028 Background: VEGFA has become an attractive target in high grade gliomas but there is no predictor of response or toxicity to anti-VEGF therapy. We investigated here the association between functional single nucleotide polymorphism (SNP) +405 G>C (rs2010963), located in 5’ untranslated terminal region of VEGFA gene, survival, response to bevacizumab (BVZ), and vascular toxicity. Methods: The rs2010963 was analyzed in blood DNA using a Taqman SNP Genotyping Assay and confronted to Progression Free Survival (PFS), Overall Survival (OS) in the general population of gliomas, and -for the glioblastomas (GBM) treated with BVZ at recurrence- with Response, PFS, and thrombo-hemorragic events. Results: In the general population of 954 gliomas stratified per grade (362 grade 2, 269 grade 3, 323 grade 4) there was no association between rs2010963 and OS or PFS. In the population of 123 recurrent GBM treated with BVZ, we observed a favourable trend in PFS associated with the C allele of rs2010963 (5.4 vs 4.2 months, p = 0.07). Most importantly the CC genotype was associated with the occurrence of thrombo-hemorragic events (6/16 vs 2/107 in CG+GG, p <0.0001). Conclusions: Our data suggest that rs2010963 status has not prognostic significance in gliomas, but is associated with vascular events in recurrent GBM treated with BVZ. The impact of rs2010963 on response to BVZ needs to be further investigated.


2021 ◽  
Vol 69 ◽  
pp. 105-110
Author(s):  
Arttu Holkeri ◽  
Antti Eranti ◽  
M. Anette E. Haukilahti ◽  
Tuomas Kerola ◽  
Tuomas V. Kenttä ◽  
...  

2019 ◽  
Vol 123 (2) ◽  
pp. 267-273 ◽  
Author(s):  
Arttu Holkeri ◽  
Antti Eranti ◽  
M. Anette Haukilahti ◽  
Tuomas Kerola ◽  
Tuomas V. Kenttä ◽  
...  

2020 ◽  
Vol 52 (3-4) ◽  
pp. 63-73
Author(s):  
Tiia Istolahti ◽  
Antti Eranti ◽  
Heini Huhtala ◽  
Leo-Pekka Lyytikäinen ◽  
Mika Kähönen ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document